Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 630179, 13 pages
http://dx.doi.org/10.1155/2015/630179
Research Article

A Tetrameric Peptide Derived from Bovine Lactoferricin Exhibits Specific Cytotoxic Effects against Oral Squamous-Cell Carcinoma Cell Lines

1Cellular and Molecular Physiology Group, Biomedical Research Institute, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia
2Department of Pharmacy, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá 111321, Colombia
3Department of Chemistry, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá 111321, Colombia
4Centro de Medicina Regenerativa, Faculty of Medicine, Clínica Alemana, Universidad del Desarrollo, 7690000 Santiago, Chile

Received 1 June 2015; Revised 16 September 2015; Accepted 28 September 2015

Academic Editor: Paul M. Tulkens

Copyright © 2015 Víctor A. Solarte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Capote, V. Escorial, M. F. Muñoz-Guerra, F. J. Rodriguez-Campo, C. Gamallo, and L. Naval, “Elective neck dissection in early-stage oral squamous cell carcinoma—does it influence recurrence and survival?” Head and Neck, vol. 29, no. 1, pp. 3–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ferlito, C. E. Silver, and A. Rinaldo, “Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies,” British Journal of Oral and Maxillofacial Surgery, vol. 47, no. 1, pp. 5–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. T. Hill and L. A. Price, “Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate,” American Journal of Clinical Oncology, vol. 17, no. 1, pp. 1–5, 1994. View at Google Scholar · View at Scopus
  4. J. P. Shah and Z. Gil, “Current concepts in management of oral cancer—surgery,” Oral Oncology, vol. 45, no. 4-5, pp. 394–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. B. Epstein, J. Thariat, R.-J. Bensadoun et al., “Oral complications of cancer and cancer therapy: from cancer treatment to survivorship,” CA: A Cancer Journal for Clinicians, vol. 62, no. 6, pp. 400–422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. T. Sonis, “The pathobiology of mucositis,” Nature Reviews Cancer, vol. 4, no. 4, pp. 277–284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Minicucci, G. N. da Silva, and D. M. Salvadori, “Relationship between head and neck cancer therapy and some genetic endpoints,” World Journal of Clinical Oncology, vol. 5, no. 2, pp. 93–102, 2014. View at Google Scholar
  8. A. D. Rapidis, P. Gullane, J. D. Langdon, J. L. Lefebvre, C. Scully, and J. P. Shah, “Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer,” Oral Oncology, vol. 45, no. 4-5, pp. 299–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Scully and J. V. Bagan, “Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications,” Oral Diseases, vol. 15, no. 6, pp. 388–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. K. Markopoulos, “Current aspects on oral squamous cell carcinoma,” Open Dentistry Journal, vol. 6, no. 1, pp. 126–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Brock, “The physiology of lactoferrin,” Biochemistry and Cell Biology, vol. 80, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Brock, “Lactoferrin-50 years on,” Biochemistry and Cell Biology, vol. 90, no. 3, pp. 245–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Freiburghaus, B. Janicke, H. Lindmark-Månsson, S. M. Oredsson, and M. A. Paulsson, “Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line,” Journal of Dairy Science, vol. 92, no. 6, pp. 2477–2484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tsuda, K. Sekine, N. Takasuka, H. Toriyama-Baba, and M. Iigo, “Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals,” BioFactors, vol. 12, no. 1–4, pp. 83–88, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Iigo, T. Kuhara, Y. Ushida, K. Sekine, M. A. Moore, and H. Tsuda, “Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice,” Clinical and Experimental Metastasis, vol. 17, no. 1, pp. 35–40, 1999. View at Google Scholar · View at Scopus
  16. T. Kozu, G. Iinuma, Y. Ohashi et al., “Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial,” Cancer Prevention Research, vol. 2, no. 11, pp. 975–983, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Masuda, H. Wanibuchi, K. Sekine et al., “Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis,” Japanese Journal of Cancer Research, vol. 91, no. 6, pp. 582–588, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ushida, K. Sekine, T. Kuhara et al., “Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat,” Japanese Journal of Cancer Research, vol. 90, no. 3, pp. 262–267, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Wolf, G. Li, A. Varadhachary et al., “Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo,” Clinical Cancer Research, vol. 13, no. 5, pp. 1601–1610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yamada, R. Sato, S. Kobayashi et al., “The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cells,” Journal of Veterinary Medical Science, vol. 70, no. 5, pp. 443–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Kanwar, K. P. Palmano, X. Sun et al., “‘Iron-saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy,” Immunology and Cell Biology, vol. 86, no. 3, pp. 277–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Bhatia, “Bovine lactoferrin, human lactoferrin, and bioactivity,” Journal of Pediatric Gastroenterology and Nutrition, vol. 53, no. 6, p. 589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. W. McKeown, F. T. Lundy, J. Nelson et al., “The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro,” Oral Oncology, vol. 42, no. 7, pp. 685–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Tsuda, K. Sekine, K.-I. Fujita, and M. Iigo, “Cancer prevention by bovine lactoferrin and underlying mechanisms—a review of experimental and clinical studies,” Biochemistry and Cell Biology, vol. 80, no. 1, pp. 131–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Tsuda, Y. Ohshima, H. Nomoto et al., “Cancer prevention by natural compounds,” Drug Metabolism and Pharmacokinetics, vol. 19, no. 4, pp. 245–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K.-I. Fujita, E. Matsuda, K. Sekine, M. Iigo, and H. Tsuda, “Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats,” Carcinogenesis, vol. 25, no. 10, pp. 1961–1966, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. A. Spagnuolo, R. P. Bird, and L. Hoffman-Goetz, “Effect of short-term dietary intake of bovine lactoferrin on intestinal lymphocyte apoptosis in healthy mice,” Nutrition, vol. 23, no. 11-12, pp. 812–817, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shimamura, Y. Yamamoto, H. Ashino et al., “Bovine lactoferrin inhibits tumor-induced angiogenesis,” International Journal of Cancer, vol. 111, no. 1, pp. 111–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. J. Vogel, D. J. Schibli, W. Jing, E. M. Lohmeier-Vogel, R. F. Epand, and R. M. Epand, “Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides,” Biochemistry and Cell Biology, vol. 80, no. 1, pp. 49–63, 2002. View at Google Scholar
  30. S. Farnaud, A. Patel, E. W. Odell, and R. W. Evans, “Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling,” FEMS Microbiology Letters, vol. 238, no. 1, pp. 221–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. B. Strøm, O. Rekdal, and J. S. Svendsen, “Antibacterial activity of 15-residue lactoferricin derivatives,” Journal of Peptide Research, vol. 56, no. 5, pp. 265–274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Wakabayashi, M. Takase, and M. Tomita, “Lactoferricin derived from milk protein lactoferrin,” Current Pharmaceutical Design, vol. 9, no. 16, pp. 1277–1287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-C. Yoo, S. Watanabe, R. Watanabe, K. Hata, K.-I. Shimazaki, and I. Azuma, “Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice,” Japanese Journal of Cancer Research, vol. 88, no. 2, pp. 184–190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. J. L. Gifford, H. N. Hunter, and H. J. Vogel, “Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties,” Cellular and Molecular Life Sciences, vol. 62, no. 22, pp. 2588–2598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Tomita, H. Wakabayashi, K. Shin, K. Yamauchi, T. Yaeshima, and K. Iwatsuki, “Twenty-five years of research on bovine lactoferrin applications,” Biochimie, vol. 91, no. 1, pp. 52–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. T. Eliassen, G. Berge, A. Leknessund et al., “The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo,” International Journal of Cancer, vol. 119, no. 3, pp. 493–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-C. Yoo, S. Watanabe, R. Watanabe, K. Hata, K.-I. Shimazaki, and I. Azuma, “Bovine lactoferrin and lactoferricin(TM) inhibit tumor metastasis in mice,” Advances in Experimental Medicine and Biology, vol. 443, pp. 285–291, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Fischer, H. Debbabi, A. Blais et al., “Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues,” International Immunopharmacology, vol. 7, no. 10, pp. 1387–1393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita, “Identification of the bactericidal domain of lactoferrin,” Biochimica et Biophysica Acta—Protein Structure and Molecular, vol. 1121, no. 1-2, pp. 130–136, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. J. S. Mader, A. Richardson, J. Salsman et al., “Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria,” Experimental Cell Research, vol. 313, no. 12, pp. 2634–2650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. S. Mader, J. Salsman, D. M. Conrad, and D. W. Hoskin, “Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines,” Molecular Cancer Therapeutics, vol. 4, no. 4, pp. 612–624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. Hilchie, R. Vale, T. S. Zemlak, and D. W. Hoskin, “Generation of a hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin,” Experimental and Molecular Pathology, vol. 95, no. 2, pp. 192–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. T. Eliassen, G. Berge, B. Sveinbjørnsson, J. S. Svendsen, L. H. Vorland, and Ø. Rekdal, “Evidence for a direct antitumor mechanism of action of bovine lactoferricin,” Anticancer Research, vol. 22, no. 5, pp. 2703–2710, 2002. View at Google Scholar · View at Scopus
  44. S. Riedl, D. Zweytick, and K. Lohner, “Membrane-active host defense peptides—challenges and perspectives for the development of novel anticancer drugs,” Chemistry and Physics of Lipids, vol. 164, no. 8, pp. 766–781, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. J. Furlong, J. S. Mader, and D. W. Hoskin, “Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts,” Experimental and Molecular Pathology, vol. 88, no. 3, pp. 371–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. K. Roy, Y. Kuwabara, K. Hara, Y. Watanabe, and Y. Tamai, “Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells,” Journal of Dairy Science, vol. 85, no. 9, pp. 2065–2074, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Amblard, J.-A. Fehrentz, J. Martinez, and G. Subra, “Methods and protocols of modern solid phase peptide synthesis,” Molecular Biotechnology, vol. 33, no. 3, pp. 239–254, 2006. View at Publisher · View at Google Scholar
  48. L. T. Eliassen, B. E. Haug, G. Berge, and Ø. Rekdal, “Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications,” Journal of Peptide Science, vol. 9, no. 8, pp. 510–517, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Thiagarajan and N. G. Iyer, “Radiation-induced sarcomas of the head and neck,” World Journal of Clinical Oncology, vol. 5, no. 5, pp. 973–981, 2014. View at Publisher · View at Google Scholar
  50. A. Carlotto, V. L. Hogsett, E. M. Maiorini, J. G. Razulis, and S. T. Sonis, “The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue,” PharmacoEconomics, vol. 31, no. 9, pp. 753–766, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Yang, T. Lejon, and Ø. Rekdal, “Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide,” Journal of Peptide Science, vol. 9, no. 5, pp. 300–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Richardson, R. de Antueno, R. Duncan, and D. W. Hoskin, “Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 736–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. H. Medina and M. E. H. El-Sayed, “Dendrimers as carriers for delivery of chemotherapeutic agents,” Chemical Reviews, vol. 109, no. 7, pp. 3141–3157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. R. Stampfer and P. Yaswen, “Human epithelial cell immortalization as a step in carcinogenesis,” Cancer Letters, vol. 194, no. 2, pp. 199–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Housman, S. Byler, S. Heerboth et al., “Drug resistance in cancer: an overview,” Cancers, vol. 6, no. 3, pp. 1769–1792, 2014. View at Publisher · View at Google Scholar
  56. W.-R. Pan, P.-W. Chen, Y.-L. S. Chen, H.-C. Hsu, C.-C. Lin, and W.-J. Chen, “Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage,” Journal of Dairy Science, vol. 96, no. 12, pp. 7511–7520, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. D. I. Chan, E. J. Prenner, and H. J. Vogel, “Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action,” Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1184–1202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. L. C. Moriarty, C. L. Joannou, J. J. M. van den Berg, B. Gorinsky, and R. W. Evans, “Factors contributing to the potency of antimicrobial cationic peptides from the N-terminal region of human lactoferrin,” FEMS Microbiology Letters, vol. 239, no. 2, pp. 295–299, 2004. View at Publisher · View at Google Scholar · View at Scopus